<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04058496</url>
  </required_header>
  <id_info>
    <org_study_id>Wnt-study</org_study_id>
    <nct_id>NCT04058496</nct_id>
  </id_info>
  <brief_title>The Importance of Wnt-signaling After Cardiac Surgery</brief_title>
  <official_title>The Importance of Wnt-signaling in the Pathobiology of Systemic Inflammation and Organ Dysfunction After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alain Rudiger</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac surgery saves lives when patients suffer from cardiac disease. Local inflammation is
      important for tissue repair and wound healing after such an operation. Inflammation starts
      already when the patient is treated in the intensive care unit. When inflammatory proteins
      (cytokines) are released into the circulation, they cause also a systemic inflammation, which
      alerts the immune system of the body and activates defence mechanisms (=adaptive response).
      In some patients, systemic inflammation is out of control thereby causing organ dysfunctions,
      shock, and in the most severe cases even death (=maladaptive response). The aim of this study
      is to investigate the early phase of inflammation after the operation. Repeated blood samples
      will be taken of patients undergoing cardiac surgery to describe the patterns and dynamics of
      inflammation proteins. A better understanding of these mechanisms will potentially lead to
      improved treatment of patients after cardiac surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this project is to understand early inflammation mechanisms after cardiac surgery.
      Therefore, repeated blood samples of patients undergoing cardiac surgery will be taken.
      Patients are selected after &quot;open&quot; cardiac surgery (via sternotomy), when when they require
      postoperative care in the cardiovascular intensive care unit. The blood samples will be
      analysed in collaboration with the Inflammation Research Unit of the Department of Internal
      Medicine at the University Hospital Zurich.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma concentration of Wnt5a (ng/ml)</measure>
    <time_frame>Up to 48 hours after ICU admission</time_frame>
    <description>Measured by a commercially available ELISA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma concentration of sFRP1 (ng/ml)</measure>
    <time_frame>Up to 48 hours after ICU admission</time_frame>
    <description>Measured by a commercially available ELISA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma concentration of sFRP5 (ng/ml)</measure>
    <time_frame>Up to 48 hours after ICU admission</time_frame>
    <description>Measured by a commercially available ELISA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma concentration of WIF-1 (pg/ml)</measure>
    <time_frame>Up to 48 hours after ICU admission</time_frame>
    <description>Measured by a commercially available ELISA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Daily fluid balance (ml)</measure>
    <time_frame>Up to 48 hours after ICU admission</time_frame>
    <description>Routine parameter taken from charts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of complications (yes/no): composite endpoint of hemodynamic instability (defined as norepinephrine concentration = or &gt; 0.1mcg/kg/min), delirium (defined as ICDSC score = or &gt; 4), infections</measure>
    <time_frame>Up to 7 days after ICU admission</time_frame>
    <description>Routine parameter taken from charts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay (days)</measure>
    <time_frame>Up to 4 weeks</time_frame>
    <description>Routine parameter taken from charts</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Inflammation</condition>
  <condition>Thoracic Surgery</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Coronary artery bypass surgery off-pump (n=20)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Coronary artery bypass surgery on-pump (n=20)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Coronary artery bypass surgery plus valve surgery (n=20)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>Five Timepoints: baseline (pre-operative), ICU admission, 4 hours after ICU admission, 8 hours after ICU admission, 48 hours after ICU admission</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients after open cardiac surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cardiac surgery via sternotomy

          -  Coronary-bypass bypass surgery with or without valve surgery

          -  Postoperative hospitalisation in the cardio-surgical ICU

          -  Available informed consent

        Exclusion Criteria:

          -  Preoperative infections (e.g. endocarditis)

          -  Preoperative use of steroids or other immunosuppression
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alain Rudiger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gabriela Spahn, MD</last_name>
    <phone>+41442551111</phone>
    <email>gabriela.spahn@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bernard Kr端ger, MD</last_name>
    <phone>+41442551111</phone>
    <email>bernard.krueger@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Z端rich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriela Spahn, MD</last_name>
      <phone>+41442551111</phone>
      <email>gabriela.spahn@usz.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Hauffe T, Kr端ger B, Bettex D, Rudiger A. Shock Management for Cardio-surgical ICU Patients - The Golden Hours. Card Fail Rev. 2015 Oct;1(2):75-82. doi: 10.15420/cfr.2015.1.2.75.</citation>
    <PMID>28785436</PMID>
  </reference>
  <reference>
    <citation>Hauffe T, Kr端ger B, Bettex D, Rudiger A. Shock Management for Cardio-surgical Intensive Care Unit Patient: The Silver Days. Card Fail Rev. 2016 May;2(1):56-62. doi: 10.15420/cfr.2015:27:2.</citation>
    <PMID>28785454</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>June 21, 2019</study_first_submitted>
  <study_first_submitted_qc>August 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2019</study_first_posted>
  <last_update_submitted>August 13, 2019</last_update_submitted>
  <last_update_submitted_qc>August 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Alain Rudiger</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Cardia surgery</keyword>
  <keyword>Cardio-pulmonary bypass</keyword>
  <keyword>Inflammation</keyword>
  <keyword>WNT</keyword>
  <keyword>Cytokines</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

